• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

National Institutes of Health

Delpor wins $1.5m NIH grant for diabetes drug implant

June 14, 2017 By Sarah Faulkner

Delpor

Delpor Inc. said today that it won a $1.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to support the development of its exenatide implant. The implant was designed for patients with Type II diabetes and features Delpor’s Nanopor technology, which uses passive diffusion to deliver therapeutic levels of exenatide […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Implants, Pharmaceuticals, Research & Development Tagged With: delpor, National Institutes of Health

Trump proposes deep cuts to Medicaid, NIH funding

May 23, 2017 By Sarah Faulkner

Capitol Hill

President Donald Trump’s proposed budget would slash Medicaid funding and cut support for major biomedical research programs at the National Institutes of Health and the Centers for Disease Control & Prevention. The budget blueprint drew condemnation from healthcare advocates and lawmakers from both sides of the aisle. Senate majority whip Sen. John Cornyn (R-Texas) reportedly said earlier […]

Filed Under: Featured, Food & Drug Administration (FDA), Funding Roundup, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Capitol Hill, Centers for Medicare and Medicaid Services (CMS), National Institutes of Health

Systemic therapy beats Bausch & Lomb implant in NIH uveitis study

May 8, 2017 By Sarah Faulkner

National Eye Institute

Systemic therapy of corticosteroids and immunosuppressants better preserved vision in patients with uveitis compared to Bausch & Lomb‘s long-lasting corticosteroid intraocular implant in a clinical trial supported by the National Eye Institute, a branch of the National Institutes of Health. In 7 years, visual acuity remained stable in patients receiving systemic therapy and declined by […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Implants, Optical/Ophthalmic, Wall Street Beat Tagged With: bausch&lomb, National Institutes of Health

Lyndra gets boost for drug delivery platform from U.S. allergy institute

May 2, 2017 By Sarah Faulkner

Lyndra

Lyndra said today that it won a 5-year grant from the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health. The grant is slated to support the formulation and preclinical development of a once-weekly oral HIV treatment. The Watertown, Mass.-based company makes use of a sustained-release technology developed by Robert […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Research & Development Tagged With: lyndra, Massachusetts Institute of Technology, National Institutes of Health

Antidepressant could help get drugs across blood-brain barrier

April 27, 2017 By Sarah Faulkner

National Institutes of Health

Researchers at the National Institutes of Health have found that pairing an antidepressant with neurological drugs can enhance drug delivery to the brain. The team’s research was published online in the Journal of Cerebral Blood Flow and Metabolism. The team cautioned that more work needs to be done to determine if the discovery will hold up […]

Filed Under: Featured, Neurological, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

Trump to meet with biotech execs, researchers to discuss federal funding

April 24, 2017 By Sarah Faulkner

capitol hill

In the wake of President Donald Trump’s $6 billion proposed cut to the National Institutes of Health, biotech executives and researchers are slated to meet with the new administration next month. A memo about the meeting reportedly describes the get-together as a chance for the “private sector and thought leaders to describe their institution and […]

Filed Under: Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: National Institutes of Health

Patients twice as likely to take anticoagulants with artificial intelligence platform

April 7, 2017 By Sarah Faulkner

Patients twice as likely to take anticoagulants with artificial intelligence platform

Researchers from the Stern Stroke Center at Montefiore Medical Center published trial results this week showing that stroke survivors were twice as likely to take anticoagulants when using an artificial intelligence platform compared to patients receiving standard therapies. The AI platform, AiCure, features software algorithms on smartphones that confirm patient identify, medication and drug ingestion. […]

Filed Under: Big Data, Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Vascular Tagged With: AiCure, National Institutes of Health

Cardiologists: $6B NIH cut a ‘catastrophe’

March 28, 2017 By Sarah Faulkner

capitol hill

Top heart doctors and researchers reportedly described President Donald Trump’s proposed 20% cut to the National Institutes of Health budget as “chilling” and a “catastrophe” at the American College of Cardiology meeting this month. Many expressed fears that as drug companies shift their focus to oncology and rare diseases, NIH-funded research will become more important to […]

Filed Under: Cardiovascular, Featured, Pharmaceuticals, Wall Street Beat Tagged With: National Institutes of Health

3D model of female reproductive system could help test drugs for efficacy, safety

March 28, 2017 By Sarah Faulkner

3D model of female reproductive system could help test drugs for efficacy, safety

In January last year, the National Institutes of Health issued a new requirement for grant funding in basic science: Researchers must discuss how gender as a biological variable will impact their research. Teresa Woodruff, director of the Women’s Health Research Institute at Northwestern University, told Drug Delivery Business News that this helped support their effort to develop a model that […]

Filed Under: Featured, Pharmaceuticals, Preclinical Trials, Research & Development, Stem Cells, Women's Health Tagged With: Draper, National Institutes of Health, Northwestern University, Pfizer Inc., University of Illinois at Chicago

Study evaluates drug-device combo therapy for deep vein thrombosis

March 6, 2017 By Sarah Faulkner

Study evaluates drug-device combo therapy for deep vein thrombosis

A National Institutes of Health-sponsored study found that most patients with deep vein thrombosis should be treated with anticoagulant drugs alone, without a procedure-based intervention. However, the same study showed that a minimally-invasive catheter-director therapy, pharmacomechanical catheter-directed thrombolysis, provided greater initial pain relief and could prevent disability in DVT patients. The research was presented today […]

Filed Under: Clinical Trials, Featured, Research & Development, Vascular Tagged With: Boston Scientific, BSN Medical, Genentech, Medtronic, National Institutes of Health, Society of Interventional Radiology

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS